Evidence map›Paper›PMID 26203083›Full record

ArticleScience translational medicine2015

Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility.

Dara M Strauss-Albee, Julia Fukuyama, Emily C Liang, Yi Yao, Justin A Jarrell, Alison L Drake, John Kinuthia, Ruth R Montgomery, Grace John-Stewart, Susan Holmes and 1 more

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 1 synthesis or guideline pooled it, 191 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Dara M Strauss-AlbeeStanford Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA. Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Julia FukuyamaDepartment of Statistics, Stanford University, Stanford, CA 94305, USA.
Emily C LiangDepartment of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Yi YaoDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06519, USA.
Justin A JarrellStanford Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA. Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Alison L DrakeDepartment of Global Health, University of Washington, Seattle, WA 98195, USA.
John KinuthiaDepartment of Research and Programs, Kenyatta National Hospital, Nairobi 00202, Kenya.
Ruth R MontgomeryDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06519, USA.
Grace John-StewartDepartment of Global Health, University of Washington, Seattle, WA 98195, USA. Department of Epidemiology, University of Washington, Seattle, WA 98195, USA. Department of Medicine, University of Washington, Seattle, WA 98195, USA. Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.
Susan HolmesDepartment of Statistics, Stanford University, Stanford, CA 94305, USA.
Catherine A BlishStanford Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA. Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. cblish@stanford.edu.
Stanford University · USUniversity of Washington · USYale University · USKenyatta National Hospital · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart · 1988 to 2026
$104.9M
Systems investigation of vaccine responses in B cell depleted autoimmune patientsU19AI089992 · NIAID · YALE UNIVERSITY · PI Steven H. Kleinstein · 2010 to 2026
$50.4M
MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Vaginal Health and the Risk of HIV-1 Acquistion in Kenyan WomenP01HD064915 · NICHD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI JOHN-STEWART, GRACE C. · 2009 to 2013
$8.9M
Modeling the influence of sex on natural killer cell networksDP2AI112193 · NIAID · STANFORD UNIVERSITY · PI BLISH, CATHERINE A · 2013 to 2015
$2.5M
Pediatric HIV-1 in Africa: Pathogenesis and ManagementK24HD054314 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2006 to 2016
$1.2M
Defining the Natural Killer Cell Response to HIVF31AI118469 · NIAID · STANFORD UNIVERSITY · PI STRAUSS-ALBEE, DARA · 2015 to 2015
$43k
NIAID NIH HHS DP2 AI112193NIAID NIH HHS DP2AI11219301NIAID NIH HHS F31 AI118469NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI27757NIAID NIH HHS T32 AI007290NIAID NIH HHS U19 AI089992NIAID NIH HHS U19AI089992NICHD NIH HHS K24 HD054314NICHD NIH HHS P01 HD064915PHS HHS P01 HSD 064915
6 · The paper itself

Abstract

Innate natural killer (NK) cells are diverse at the single-cell level because of variegated expressions of activating and inhibitory receptors, yet the developmental roots and functional consequences of this diversity remain unknown. Because NK cells are critical for antiviral and antitumor responses, a better understanding of their diversity could lead to an improved ability to harness them therapeutically. We found that NK diversity is lower at birth than in adults. During an antiviral response to either HIV-1 or West Nile virus, NK diversity increases, resulting in terminal differentiation and cytokine production at the cost of cell division and degranulation. In African women matched for HIV-1 exposure risk, high NK diversity is associated with increased risk of HIV-1 acquisition. Existing diversity may therefore decrease the flexibility of the antiviral response. Collectively, the data reveal that human NK diversity is a previously undefined metric of immune history and function that may be clinically useful in forecasting the outcomes of infection and malignancy.

Indexed as

ImmunityAdultCytokinesDisease SusceptibilityFemaleHIV-1HIV InfectionsHumansKenyaKiller Cells, NaturalTissue DonorsCytokines

Identifiers

PMID26203083
PMCPMC4547537
OpenAlexW1801065823

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.